The store will not work correctly when cookies are disabled.
5-(2-(2-(2-(2-Ethyl-3-hydroxy-4-oxopyridin-1(4H)-yl)ethoxy)-ethoxy)ethoxy)-2,5-dioxopentan-1-aminium Chloride
ID: ALA4066692
PubChem CID: 137631714
Max Phase: Preclinical
Molecular Formula: C18H29ClN2O7
Molecular Weight: 384.43
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: CCc1c(O)c(=O)ccn1CCOCCOCCOC(=O)CCC(=O)CN.Cl
Standard InChI: InChI=1S/C18H28N2O7.ClH/c1-2-15-18(24)16(22)5-6-20(15)7-8-25-9-10-26-11-12-27-17(23)4-3-14(21)13-19;/h5-6,24H,2-4,7-13,19H2,1H3;1H
Standard InChI Key: FWSHPZFARNKHOY-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 27 0 0 0 0 0 0 0 0999 V2000
14.8893 -10.6071 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2.1323 -8.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1323 -9.1927 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8453 -9.5993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5583 -9.1927 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.5583 -8.3672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8453 -7.9483 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.4156 -7.9545 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.4174 -9.6045 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2.8453 -10.4248 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1298 -10.8396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2733 -9.6045 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9852 -9.1948 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.7000 -9.6065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.4161 -9.1968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.1310 -9.6086 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8470 -9.1989 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.5619 -9.6106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.2780 -9.2010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.9929 -9.6127 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.7048 -9.2031 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4196 -9.6147 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7060 -8.3776 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.1358 -9.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8506 -9.6169 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5667 -9.2072 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8494 -10.4424 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2816 -9.6189 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2 3 1 0
2 7 1 0
3 4 2 0
4 5 1 0
5 6 1 0
6 7 2 0
2 8 2 0
3 9 1 0
4 10 1 0
10 11 1 0
5 12 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 21 1 0
21 22 1 0
21 23 2 0
22 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
26 28 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 384.43 | Molecular Weight (Monoisotopic): 384.1897 | AlogP: 0.00 | #Rotatable Bonds: 14 |
Polar Surface Area: 130.08 | Molecular Species: NEUTRAL | HBA: 9 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 11.54 | CX Basic pKa: 7.83 | CX LogP: 0.02 | CX LogD: -0.55 |
Aromatic Rings: 1 | Heavy Atoms: 27 | QED Weighted: 0.34 | Np Likeness Score: -0.30 |
References
1. Battah S, Hider RC, MacRobert AJ, Dobbin PS, Zhou T.. (2017) Hydroxypyridinone and 5-Aminolaevulinic Acid Conjugates for Photodynamic Therapy., 60 (8): [PMID:28363026] [10.1021/acs.jmedchem.7b00346] |